MedTrace Logo

A Study That Will Look at the Impact of Immunosuppression on Antibody Production in Kidney Transplant Recipients.

NCT00275717 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2010-12-22

No results posted yet for this study

Summary

This study is being done to collect blood and bone marrow samples for biologic studies of antibody producing cells. Donor specific antibodies can cause damage to the kidneys after they are transplanted. The study will look at the impact of immunosuppression on antibody production by antibody producing cells.

Conditions

  • Kidney Transplant

Sponsors & Collaborators

  • Genzyme, a Sanofi Company

    collaborator INDUSTRY

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Mark D. Stegall, M.D. · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-03-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00275717 on ClinicalTrials.gov